Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi.

ABSTRACT:

SUBMITTER: Sacchi S 

PROVIDER: S-EPMC5004354 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature